Filing Details

Accession Number:
0001209191-21-013486
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-23 19:44:40
Reporting Period:
2021-02-19
Accepted Time:
2021-02-23 19:44:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1754068 Allovir Inc. ALVR Biological Products, (No Disgnostic Substances) (2836) 831971007
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1755495 Juan Vera C/O Allovir, Inc.
139 Main Street, Suite 500
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-19 13,233 $41.79 2,426,935 No 4 S Direct
Common Stock Disposition 2021-02-22 2,891 $41.58 2,424,044 No 4 S Direct
Common Stock Disposition 2021-02-22 11,050 $42.80 2,412,994 No 4 S Direct
Common Stock Disposition 2021-02-22 380 $43.40 2,412,614 No 4 S Direct
Common Stock Disposition 2021-02-23 1,125 $38.33 2,411,489 No 4 S Direct
Common Stock Disposition 2021-02-23 4,825 $39.11 2,406,664 No 4 S Direct
Common Stock Disposition 2021-02-23 2,300 $40.13 2,404,364 No 4 S Direct
Common Stock Disposition 2021-02-23 600 $40.97 2,403,764 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.34 to $42.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.25 to $42.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.31 to $43.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.34 to $43.49. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.74 to $38.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.75 to $39.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.76 to $40.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.77 to $41.225. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.